期刊文献+

平均血小板体积在不稳定型心绞痛患者冠状动脉愈合斑块中的预测价值 被引量:2

Predictive value of mean platelet volume in coronary artery healed plaque in patients with unstable angina pectoris
下载PDF
导出
摘要 目的 观察不稳定型心绞痛(UAP)患者平均血小板体积(MPV)的水平变化,并探讨其对冠状动脉罪犯血管处愈合斑块的预测价值。方法 选取2020年1月~2023年1月于新疆医科大学第一附属医院心脏中心行冠状动脉造影(CAG)与造影后即刻对冠状动脉罪犯血管行光学相关断层成像扫描(OCT)的UAP患者110例。根据OCT图像斑块特征,将患者分为愈合斑块组(50例)和非愈合斑块组(60例)。比较两组患者临床资料及生化指标,应用多因素logistic回归分析愈合斑块的独立危险因素,采用受试者工作特征(ROC)曲线分析MPV水平变化对愈合斑块的预测价值。结果 愈合斑块组尿酸、MPV、血小板分布宽度(PDW)、病变长度[(361.20±91.34)mmol/L比(325.73±75.70)mmol/L、(10.71±0.81)fL比(9.95±0.86)fL、(11.88±1.84)%比(11.14±17.01)%、11.38(8,15)mm比8.98(8,10)mm]高于非愈合斑块组(P<0.05),白蛋白、高密度脂蛋白水平[(42.23±3.09)g/L比(43.94±3.55)g/L、(0.91±0.25)mmol/L比(1.01±0.21)mmol/L]低于非愈合斑块组(P<0.05)。OCT斑块特征分析得出,愈合斑块组巨噬细胞分级更高、钙化小结比例[(50.0)%比(30.0)%、(22.0)%比(5.0)%]高于非愈合斑块组(P<0.05)。Spearman相关性分析显示,MPV与易损斑块(TCFA)呈正相关性(r=0.680,P<0.001)。多因素logistic回归分析结果显示,MPV、白蛋白是UAP患者罪犯血管处愈合斑块的独立预测因素。ROC曲线分析显示,当MPV=10.05 fL时对愈合斑块的诊断效能较高,用于预测愈合斑块发生的曲线下面积为0.751(95%CI 0.659~0.842,P<0.001)。结论 在UAP患者的冠状动脉罪犯血管处,愈合斑块与斑块易损性相关,MPV水平变化对愈合斑块具有较高的诊断价值。 Objective To investigate the changes in the level of mean platelet volume(MPV)in patients with unstable angina pectoris(UAP)and its predictive value for healed plaques at coronary culprit vessels.Methods A total of 110 patients with UAP who underwent coronary angiography(CAG)and optical coherence tomography(OCT)of the coronary culprit vessels immediately after CAG in the First Affiliated Hospital of Xinjiang Medical University from January 2020 to January 2023 were included.According to the plaque characteristics of the OCT images,the patients were divided into healed plaque groups(50 cases)and non-healed plaque group(60 cases).The clinical data and biochemical indexes of the two groups were compared.Independent risk factors of healed plaques were analyed by multivariate logistic regression,and the predictive value of changes in MPV levels on healed plaque analysed using receiver operating characteristic(ROC)curves.Results In the healed plaque group,Uric acid,MPV,platelet distribution width(PDW),and lesion length[(361.20±91.34)mmol/L vs.(325.73±75.70)mmol/L,(10.71±0.81)fL vs.(9.95±0.86)fL,(11.88±1.84)%vs.(11.14±17.01)%,11.38(8,15)mm vs.8.98(8,10)mm]was higher than the non-healing plaque group(P<0.05),and albumin and HDL levels[(42.23±3.09)g/L vs.(43.94±3.55)g/L,(0.91±0.25)mmol/L vs.(1.01±0.21)mmol/L]were lower than the nonhealed plaque group.In the healed plaque group,macrophage grading and the proportion of calcified nodules[(50.0)%vs.(30.0)%and(22.0)%vs.(5.0)%]were higher than in the non-healed plaque group(P<0.05)on OCT plaque characterization.Correlation analysis showed that MPV positively correlated with vulnerable plaque(TCFA)(r=0.680,P<0.001).Multivariate logistic regression analysis showed that MPV and albumin were the influencing factors for healed plaque at the coronary culprit vessel in UAP patients.ROC curves analysis showed a higher diagnostic efficacy for healed plaque when MPV=10.05 fL and the area under the curve(AUC)for MPV for predicting the occurrence of healed plaque was 0.751(95%CI 0.659-0.842,P<0.001).Conclusions Healed plaque correlates with plaque vulnerability at the coronary culprit vessel in patients with UAP,and the changes in MPV levels have a higher predictive value for healed plaque.
作者 于泽宁 陈清杰 李晓梅 杨毅宁 YU Ze-ning;CHEN Qing-jie;LI Xiao-mei;YANG Yi-ning(Heart Center of the First Affiliated Hospital of Xinjiang Medical University,Urumqi 830054,China;Department of Cardiology,People’s Hospital of Xinjiang Uygur Autonomous Region,Urumqi 830001,China)
出处 《中国心血管病研究》 CAS 2023年第6期518-524,共7页 Chinese Journal of Cardiovascular Research
基金 新疆维吾尔自治区高校科研计划(XJEDU2021I015)。
关键词 不稳定型心绞痛 平均血小板体积 愈合斑块 光学相关断层成像 Unstable angina pectoris Mean platelet volume Healed plaque Optical coherence tomography
  • 相关文献

参考文献1

二级参考文献24

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 3Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 4Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 8Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 9Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS) study investigator. Inhibition of the platelet giycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med,1998, 338(21) :1488-1497.

共引文献2142

同被引文献14

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部